Microbiological Spectrum and Antibiotics Sensitivity Pattern of Chronic Suppurative Otitis Media (CSOM) Patients: A prospective study from a Tertiary Care Hospital in Peshawar

慢性化脓性中耳炎(CSOM)患者的微生物谱和抗生素敏感性模式:一项来自白沙瓦三级医院的前瞻性研究

阅读:1

Abstract

BACKGROUND & OBJECTIVE: Chronic suppurative otitis media is a fatal condition owing to its propensity for intracranial extension. The inadvertent use of antibiotics has led to resistance among causative organisms. The objectives of this study were to determine causative bacteria, their antibiotic resistance and susceptibility patterns, and their response to antibiotics after a one-month follow-up. METHOD: It was a prospective study conducted in the ENT department of Khyber Teaching Hospital, Peshawar from June 2023 to March 2024. Ear swabs were collected for microscopy and bacterial culture. Statistical analysis was done using IBM-SPSS-20, and GraphPad Prism. RESULTS: Data was collected from 113 patients. The mean age of the patients was 22 + 2 years. Out of 113 samples, 97(85.5%) showed growth on culture whereas 16(14%) showed no growth, with 95 (98%) unimicrobial, while 2 (2%) showed polymicrobial growth. Pseudomonas aeruginosa was the commonest bacteria isolated 38(38%), followed by S. aureus, Proteus species, and S. saprophyticus. Gram-positive bacteria were susceptible to Linezolid (80%), followed by Vancomycin (76%), with resistance to Ciprofloxacin (75-84%), Ampicillin (70%), and Ceftriaxone (75-80%). Gram-negative bacteria showed susceptibility to carbapenem (50-100%) and Piperacillin/Tazobactam (50% to 93%), with resistance to Ciprofloxacin (50-87%), Ceftriaxone (87%), and Amoxicillin/Clavulanate (72-90%). After one month of follow-up, 82% of patients showed improvements, with noncompliance significantly associated with the persistence of symptoms (p<0.01). CONCLUSION: Moderate to high resistance against ciprofloxacin, third-generation cephalosporin, ampicillin, amoxicillin plus clavulanate, and clindamycin is an eye-opener. Our results underscore the critical need for judicious administration of empirical antibiotics.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。